Verra Therapeutics, Inc.

Lansing, NY

UEI
WTKNN246ZR43
CAGE
7U4E4
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
1939 E Shore Dr #5, Lansing, NY 14882, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
A disease-modifying protein therapeutic for the treatment of copd R44HL149580 National Heart Lung and Blood Institute (NIH) $8,093,440
A disease-modifying protein therapeutic for the treatment of copd R43HL149580 National Heart Lung and Blood Institute (NIH) $390,914

Quick answers

Is Verra Therapeutics, Inc. registered in SAM.gov?

Yes. Verra Therapeutics, Inc.'s SAM.gov registration is active through November 21, 2026.

What is Verra Therapeutics, Inc.'s most recent federal award?

Verra Therapeutics, Inc.'s most recent federal grant award is A disease-modifying protein therapeutic for the treatment of copd (R44HL149580), from National Heart Lung and Blood Institute (NIH), on September 15, 2019.

On GovTribe

See Verra Therapeutics, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login